RECRUITING

Diagnostic Strategies, Risk Assessment and Progression of Pancreatic Cysts

Study Overview

This clinical trial focuses on testing the efficacy of different digital interventions to promote re-engagement in cancer-related long-term follow-up care for adolescent and young adult (AYA) survivors of childhood cancer.

Description

The aims of this study are to determine the natural history of pancreatic cysts and to propose and prospectively validate a diagnostic approach and model for prediction of mucinous versus non-mucinous, and malignant versus non-malignant, pancreatic cysts using a combination of clinical, radiologic, and biomarker characteristics.

Official Title

Diagnostic Strategies, Risk Assessment and Progression of Pancreatic Cysts

Quick Facts

Study Start:2022-07-20
Study Completion:2036-08-01
Study Type:Not specified
Phase:Not Applicable
Enrollment:Not specified
Status:RECRUITING

Study ID

NCT04473794

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Ages Eligible for Study:18 Years
Sexes Eligible for Study:ALL
Accepts Healthy Volunteers:No
Standard Ages:ADULT, OLDER_ADULT
Inclusion CriteriaExclusion Criteria
  1. * Adult patients age 18 years and older
  2. * Referred for assessment of a pancreatic cyst.
  1. * Medically ill patients with American Society of Anesthesiologists class 4 or greater.
  2. * Inability to provide informed consent.
  3. * Pregnancy or lactation.

Contacts and Locations

Study Contact

Elham Afghani, MD MPH
CONTACT
410-614-6708
eafghan1@jhmi.edu

Principal Investigator

Elham Afghani, MD MPH
PRINCIPAL_INVESTIGATOR
Johns Hopkins University

Study Locations (Sites)

The Johns Hopkins Hospital
Baltimore, Maryland, 21287
United States

Collaborators and Investigators

Sponsor: Johns Hopkins University

  • Elham Afghani, MD MPH, PRINCIPAL_INVESTIGATOR, Johns Hopkins University

Study Record Dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Registration Dates

Study Start Date2022-07-20
Study Completion Date2036-08-01

Study Record Updates

Study Start Date2022-07-20
Study Completion Date2036-08-01

Terms related to this study

Additional Relevant MeSH Terms

  • Pancreatic Neoplasms
  • Pancreas Cancer